ArticleGlobal public health2017
The China National Tobacco Corporation: From domestic to global dragon?
Article in Global public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Bacteria in the Phylum Bacillota Degrade Nicotine Through the Variant of Pyridine and Pyrrolidine Pathway.Current microbiology · 2025Article
- Effects ofFrontiers in microbiology · 2024Article
- Activity of the Tobacco Industry in Research and Scientific Literature.Tobacco use insights · 2024Article
- A multi-country analysis of transnational tobacco companies' market share.Tobacco induced diseases · 2023Article
- A Cross-sectional Analysis of Socio-spatial Patterning of Tobacco Retail in Shanghai, China.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- A call to ban the sale of tobacco products.Frontiers in public health · 2022Article
- 'Pro-tobacco propaganda': a case study of tobacco industry-sponsored elementary schools in China.Tobacco control · 2020Article
- "All Weather Friends": How China Transformed Zimbabwe's Tobacco Sector.International journal of environmental research and public health · 2020Article
- Impact of China National Tobacco Company's 'Premiumization' Strategy: longitudinal findings from the ITC China Surveys (2006-2015).Tobacco control · 2019Article
- Looming threat of Asian tobacco companies to global health.Lancet (London, England) · 2017Article
- The globalisation strategies of five Asian tobacco companies: An analytical framework.Global public health · 2017Article
- The globalisation strategies of five Asian tobacco companies: a comparative analysis and implications for global health governance.Global public health · 2017Article
- The Taiwan Tobacco and Liquor Corporation: To 'join the ranks of global companies'.Global public health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The China National Tobacco Corporation (CNTC), which produces one-third of the world's cigarettes, is the largest tobacco company in the world. Over the past 60 years, the CNTC has been focused on supplying a huge domestic market. As the market has become increasingly saturated, and potential foreign competition looms, the company has turned to expansion abroad. This paper examines the ambitions and prospects of the CNTC to 'go global'. Using Chinese and English language sources, this paper describes the globalisation ambitions of the CNTC, and its global business strategy focused on internal restructuring, brand development and expansion of overseas operations in selected markets. The paper concludes that the company has undergone substantial change over the past two decades and is consequently poised to become a new global player in the tobacco industry. This article is part of the special issue 'The Emergence of Asian Tobacco Companies: Implications for Global Health Governance'.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.